Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo
Nobuyuki Shibusawa, Koshi Hashimoto, Amisra A. Nikrodhanond, M. Charles Liberman, Meredithe L. Applebury, Xiao Hui Liao, Janet T. Robbins, Samuel Refetoff, Ronald N. Cohen, Fredric E. Wondisford
Nobuyuki Shibusawa, Koshi Hashimoto, Amisra A. Nikrodhanond, M. Charles Liberman, Meredithe L. Applebury, Xiao Hui Liao, Janet T. Robbins, Samuel Refetoff, Ronald N. Cohen, Fredric E. Wondisford
View: Text | PDF
Article Endocrinology

Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo

  • Text
  • PDF
Abstract

Thyroid hormone action is mediated by thyroid hormone receptors (TRs), which are members of the nuclear hormone receptor superfamily. DNA-binding is presumed to be essential for all nuclear actions of thyroid hormone. To test this hypothesis in vivo, the DNA-binding domain of TR-β was mutated within its P-box (GS mutant) using gene targeting techniques. This mutation in vitro completely abolishes TR-β DNA-binding, while preserving ligand (T3) and cofactor interactions with the receptor. Homozygous mutant (TR-βGS/GS) mice displayed abnormal T3 regulation of the hypothalamic-pituitary-thyroid axis and retina identical to abnormalities previously observed in TR-β KO (TR-β–/–) mice. However, TR-βGS/GS mutant mice maintained normal hearing at certain frequencies and did not display significant outer hair cell loss, in contrast to TR-β–/– mice. DNA-binding, therefore, is essential for many functions of the TR, including retinal development and negative feedback regulation by thyroid hormone of the hypothalamic-pituitary-thyroid axis. Inner ear development, although not completely normal, can occur in the absence of TR DNA-binding, suggesting that an alternative and perhaps novel thyroid hormone-signaling pathway may mediate these effects.

Authors

Nobuyuki Shibusawa, Koshi Hashimoto, Amisra A. Nikrodhanond, M. Charles Liberman, Meredithe L. Applebury, Xiao Hui Liao, Janet T. Robbins, Samuel Refetoff, Ronald N. Cohen, Fredric E. Wondisford

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Generation of TR-βGS/GS and TR-β–/– mice. Schematic strategy of homologo...
Generation of TR-βGS/GS and TR-β–/– mice. Schematic strategy of homologous recombination in TR-βGS/GS (a) and TR-β–/– mice (b) is illustrated. Diagrams show the WT TR-β locus, the targeting vectors, ES-targeted alleles, and the F1 mutant alleles after the ACN cassette is excised. The mutated exon 3 is shown as shaded boxes. H, Hind III; K, Kpn I; RV, Eco RV; B, Bgl II; X, Xba I. The locations of ES, GS, and KO probes for Southern blot analysis are indicated. The ACN cassette is flanked by loxP sites indicated by black arrowheads. Arrows indicate the positions of PCR primers (5′, match/mismatch, KO5′, KO3′) used for DNA genotyping. The site of restriction fragments obtained by Southern blot analysis is given in kb. Chi, chimeric. (c) Southern blot analysis of DNA from ES clones. WT (11.5 kb) and targeted (8.0 kb) Hind III alleles were detected by a 3′ external ES probe. (d) Southern blot analysis of DNA from F2 mice resulting from a GS125 KI heterozygous intercross compared with chimeric animals. After Eco RV digestion, a 4.8-kb band was detected in targeted allele of chimeric mice using GS probe. After self-excision of ACN cassette, a 3.8-kb band is obtained from the mutant allele. (e) Genotyping of F2 KI offspring by mismatch PCR. The WT allele was detected with WT match primer set and mutant allele was detected only with the mismatch (mutant) primer set. (f) Southern blot analysis of TR-β KO F2 siblings using the KO probe. The mutant allele demonstrated a longer (7.8 kb) band after Kpn I digestion versus the WT allele of 3.8 kb. (g) PCR genotyping of F2 KO mice. A 300-bp shorter band is observed in DNA from the KO versus WT allele.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts